Concepedia

Christine Esau

CE

Statistics

Publications

30

Citations

9.7K

H-Index

28

Active since

1998

Affiliations

Regulus Therapeutics (United States)(Current)

Ionis Pharmaceuticals (United States)

New York University

Harvard University

Brigham and Women's Hospital

Christine Esau is an author at Regulus Therapeutics (United States) specializing in life sciences, microrna biology, and molecular biology.

ORCID

Publications per year

1998–2020

30

Publications

30

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

Christine Esau, Scott Davis, Susan Murray et al. · Cell Metabolism · 2006 · 2.1K citations · Full text

, , +16

MicroRNA-143 Regulates Adipocyte Differentiation

Christine Esau, Xiaolin Kang, Eigen Peralta et al. · Journal of Biological Chemistry · 2004 · 1K citations · Full text

, , +12

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

Galina Gabriely, Thomas Würdinger, Santosh Kesari et al. · Molecular and Cellular Biology · 2008 · 886 citations · Full text

, , +17

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

Katey J. Rayner, Christine Esau, Farah Hussain et al. · Nature · 2011 · 697 citations · Full text

, , +12

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

Katey J. Rayner, Frederick J. Sheedy, Christine Esau et al. · Journal of Clinical Investigation · 2011 · 684 citations

, , +17

1–5 of 30